A rational approach to diagnosis and treatment of intermittent claudication

American Journal of the Medical Sciences

Volumn 323, Issue 5, 2002, Pages 244-251

  Fernandez Jr , Bernardo B ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

Ankle brachial index; Cilostazol; Intermittent claudication; Pentoxifylline; Peripheral vascular disease

Indexed keywords

ARGININE; CILOSTAZOL; PENTOXIFYLLINE; PROPIONYLCARNITINE;

ANALGESIA; ANAMNESIS; ARTERY DISEASE; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DIARRHEA; DRUG CLASSIFICATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; LEG REVASCULARIZATION; META ANALYSIS; MORBIDITY; MORTALITY; NON INVASIVE MEASUREMENT; PATIENT MONITORING; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK FACTOR; SMOKING CESSATION; TREATMENT PLANNING; VERTIGO;

EID: 0036080276     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200205000-00003     Document Type: Review

References (29)

1. The prevalence of peripheral arterial disease in a defined population
2. A primary care approach to the patient with claudication
3. Management of peripheral arterial disease (PAD)
4. Pharmacological approaches to the treatment of intermittent claudication
5. Diagnosis of intermittent claudication
6. Can drugs help patients with lower limb ischaemia?
7. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review
8. Aneurysms and occlusive disease of the aorta and peripheral vessels
9. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: Results from noninvasive testing in a defined population
10. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points
11. Treating intermittent claudication secondary to peripheral arterial disease
12. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
13. The measured effect of stopping smoking on intermittent claudication
14. Some answers, more controversy, from UK-PDS
15. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis
16. Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients
17. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease
18. Management of intermittent claudication with pentoxifylline: Meta-analysis of randomized controlled trials
19. Conservative management of intermittent claudication
20. Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication
21. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease
22. Cilostazol has beneficial effects in treatment of intermittent claudication: Results from a multicenter, randomized, prospective, double-blind trial
23. A comparison of cilostazol and pentoxifylline for treating intermittent claudication
24. Propionyl-1-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose-titration, multicenter study
25. Effect of propionyl-1-carnitine on quality of life in intermittent claudication
26. European multicenter study on propionyl-1-carnitine in intermittent claudication
27. Restoring vascular nitric oxide formation by 1-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease
28. Nutritional therapy for peripheral arterial disease: A double-blind, placebo-controlled, randomized trial of HeartBar